Release Date: 23/11/09 08:24 Summary: Final Director's Interest Notices Price Sensitive: No Download Document 18.68KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%